Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Organic-Scientific Announces Limited Time 25% Off Coupon on CBD Products


News Image

25% off is an amazing deal, nice way to try out a new CBD product.

Organic-Scientific’s range of lab-tested CBD products includes oils, relief creams, capsules, and even CBD products for pets. These products are naturally produced in a lab approved by the FDA using organic, all-natural ingredients. Prospective customers are welcome to view the Kaycha Labs Certificate of Analysis by visiting the following link providing a detailed overview of the extensive testing done to ensure Organic-Scientific’s CBD products meet rigid standards: https://organic-scientific.com/wp-content/uploads/2020/02/lab-results-1.pdf.

The capsule items from Organic-Scientific, for example, treat issues like inflammation, and they may also aid with weight loss, sleep disorders like insomnia, and male enhancement. Tinctures are used in doses ranging from 500 mg to 1000 mg and from 500 to 1500 mg in creams.

The Pets Plus+ product has been independently tested for protection and consistency. It uses only two components (cannabidiol extracted from hemp and coconut oil) and is sourced from hemp grown in the United States.

To receive the 25% discount, customers should enter the coupon code OS25 during checkout. The promotion ends on November 30, 2020.

About Organic-Scientific

Organic-Scientific remains strong in its focus on delivering unbeatable quality through its all natural CBD product line. To this end, it has partnered with industry leaders and integrated the latest science and technology with established holistic solutions to give customers a truly integrative approach to their full well-being. Its CBD products are manufactured in the United States and use 100% pure organic hemp. For more information, please go to https://organic-scientific.com or visit the store at 7003 North Waterway Drive, Suite 218 Miami, FL 33155.

Share article on social media or email:

Introducing Calmy–The Bedside Storyteller That Calms Even the Most Restless Minds


News Image

Is your child ever a bit riled up when they are supposed to be winding down? This device has got you covered! Calmy will boost their imagination, foster their curiosity, make them discover new cultures, all the while helping to soothe them, and set the mood for a good night’s sleep.

Calmy is a touchscreen storyteller device that provides soothing stories, calming sounds, and light ambiances for kids of all ages, making bedtime more peaceful and easing restless minds. It features thousands of stories sorted by categories and age (new selections will be added weekly).

The Calmy Kickstarter campaign launched on Nov. 10. It’s the brainchild of JOY Familytech, developers of Octopus Watch, the first icon-based watch that teaches kids good habits and the concept of time. Octopus Watch raised more than $2 million on Kickstarter and Indiegogo and was sold in Target and Walmart.

Kids will love Calmy! It creates a relaxing atmosphere that boosts imagination, fosters curiosity, and lets kids discover new cultures, all the while helping to soothe and set the mood for a good night’s sleep. When it’s time to sleep, Calmy transforms into a nightlight, then turns into a serene alarm in the morning to make sure children always wake up on the right foot.

Calmy doubles as a circadian light with 24 multi-color LEDs that display virtually any color and is preloaded with several ambiances to produce effects for focus, calmness, and more.

Customize your Calmy with cute sticker panels that can easily be changed.

Help your child create healthy bedtime habits. Learn more about the benefits of reading at bedtime.

Follow JOY Familytech on social:

Facebook: http://facebook.com/joyfamilytech

Facebook Group: https://www.facebook.com/groups/calmy

Instagram: http://instagram.com/joyfamilytech/

About JOY Familytech:

JOY Familytech provides the training wheels for good habits. The company’s mission is to empower families by helping parents offer structure and routines in their children’s lives. This helps children develop self-discipline and self-esteem and provides them with the organizational skills necessary for a successful and happy life. The company consists of a passionate, diverse team with backgrounds in child development, engineering, business, and communication.

Share article on social media or email:



Neck Gaiters Are Effective Against Coronavirus Transmission, Says University of Georgia and Virginia Tech Studies


100% American-made neck gaiter

Do neck gaiters work as well as face masks for COVID-19 protection? New research from the University of Georgia and Virginia Tech fly in the face of Duke’s now-infamous study that condemned these versatile tubes of fabric. The more recent studies suggest that neck gaiters work well at stopping the spread of the coronavirus — and that they may actually be more effective than cloth face masks.

When Gaiter King first opened for business, it was on a mission to provide durable apparel that met the unique needs of outdoor enthusiasts and professionals in the construction, logistics, and trucking industries. But when the COVID-19 pandemic began, the company soon found that its face masks and neck gaiters were serving a different purpose: Helping people stay safe in these turbulent times.

Not long after, Duke University published a study that led media outlets to believe that neck gaiters allowed more airborne particles to spew through its fabric. The problem? This study was not meant to evaluate face mask protection options; it was actually intended to demonstrate an inexpensive method to test face mask protection efficacy, and it purposely used a thin, lightweight neck gaiter for “extra breathability.”

Since Duke University published its findings, several reputable news sources such as The New York Times, The Washington Post, and USA Today and many leading researchers have all come to the defense of neck gaiters. One of them was even a leading researcher in Duke University’s study.

“We tested one neck gaiter because we just had that mask lying around. As I mentioned, it was a pretty thin mask,” explains Dr. Martin Fischer, a Duke University Chemistry associate research professor and co-author of the study. “Our intent was not to say this mask doesn’t work, or never use neck gaiters. This was not the main part of the paper… It was not a systematic study of masks… Seeing the media somewhat misquote and misinterpret the data was a big downer.”

Now, two other academic institutions have also come to the rescue of neck gaiters: The University of Georgia and Virginia Tech.

Employing the same methodology as the Duke University study, the University of Georgia researchers used a laser, a Class 1000 clean room, and a 3D-printed box designed to reduce air particles. In this environment, they then had an adult male participant say the phrase “Stay healthy, people” five times while wearing a variety of face masks and neck gaiters. Single-layer neck gaiters reduce respiratory droplet transmission by 77%, while two-layer face masks achieved an average score of 81%. Multi-layer neck gaiters reduced respiratory droplets by 96%.

Virginia Tech, a leading authority on aerosols, also conducted its own study on single-layer and two-layer neck gaiters. Researchers at this institution found that both types of gaiters were effective at stopping 100% of large 20-micron droplets and 50% of one-micron particles. When the researchers doubled the single-layer gaiter, it blocked more than 90% of all aerosols.

The results from the University of Georgia’s and Virginia Tech’s studies have alleviated the concerns of Gaiter King’s founding members regarding misinformation about neck gaiters. But they know more work still needs to be done to vindicate neck gaiters completely. And they hope that their products’ quality will help in these efforts.

Gaiter King uses high-quality material specifically designed to combat the shortcomings of a thin fabric gaiter. The company’s neck gaiters and face masks are moisture-wicking and offer UPF 50 protection to keep users cool, dry, and guarded against the sun’s rays. Each Gaiter King product is infused with a copper and silver anti-microbial treatment that has been clinically shown to defend against most viruses, bacteria, mold, and fungus. Lastly, each Gaiter King neck gaiter can easily become two-ply just by folding them down.

Established in Southern California, Gaiter King was founded by a group of outdoor enthusiasts who create functional, fashionable, and durable apparel for nature lovers and working professionals across the agricultural, construction, logistics, and energy industries. All of Gaiter King’s face masks and neck gaiters are 100% American-made.

Share article on social media or email:

Antigen Tests Driving COVID-19 Test Market to 10.5 BN: Report


Kalorama Information logo

While antigen tests have been criticized for the lower performance characteristics compared to antibody and molecular tests, these metrics are not always the most significant.

Antigen tests, typically performed rapidly at the point of care, detect the presence of viral proteins, rather than testing for an immune response in the patient, are a significant factor in the market for COVID-19 testing already, according to market researcher Kalorama Information, part of Science and Medicine Group. In its latest COVID-19 Update report , Kalorama Information said that volume was up in labs and among IVD vendors, new technologies are available. The firm projects a 10.5 billion-dollar market for COVID-19 in vitro diagnostic test products, including PCR, antigen tests and other types of tests. This is an increase of over one billion dollars from the firm’s August update, with much of the increase based on the production and usage of antigen tests.

With over a million deaths worldwide, the COVID-19 crisis has continued to unfold with great challenges for the healthcare system and its suppliers. But creative solutions have been emerging at labs to help ease the load during a difficult time Antigen tests are among those, and major companies have launched such tests in the last six months. They are already seeing a market, according to Kalorama.

Antigen tests can offer some major benefits in the effort to control the SARS-CoV-2 pandemic. The decision to apply antigen tests in certain situations as opposed to others is complicated and is still being completely sorted out. The decision to apply antigen testing depends on variables including: sensitivity and specificity of the test, prevalence/ outbreak of COVID-19 in the given population, remote location, availability of laboratories/ hospitals, cost, ability to perform serial testing, and other factors.

The scarcity of various diagnostic test related products during the COVID-19 pandemic has further driven home the reality that different testing methods are best allocated for different situations.

“While antigen tests have been criticized for the lower performance characteristics compared to antibody and molecular tests, these metrics are not always the most significant,” said Justin Saeks, analyst for Kalorama Information and author of the report’s antigen test section. “Antigen tests often can have sensitivity lower than 85% while the specificity needs to be fairly high, in the range of 98% or higher. Although a sensitivity of roughly 80% seems striking as a low number, in fact the negative predictive value can still be sufficient if the disease prevalence is appropriately matched.”

The frequency with which PCR tests were launched and authorized in the early part of the year is now being seen with antigen tests, Kalorama said. Millions of tests are in production at the current time and more tests are in development.

Antigen tests marketed or in development include:

  • Abbott Laboratories -BinaxNow COVID-19 Ag Card & Navica app
  • BD-BD Veritor System for Rapid Detection of SARS-CoV-2
  • BIOHIT SARS-CoV-2 Antigen Rapid Test Kit (CE)
  • Edinburgh Genetics – ActivXpress+ COVID-19 Antigen Complete Testing Kit
  • FenHe Technology -reOpenTest COVID-19 Rapid Antigen Test
  • LumiraDx – SARS-CoV-2 Ag Test
  • Menarini Diagnostica/ Boditech Med – iChroma COVID-19
  • OraSure Technologies – at-home test (announced)
  • Ortho Clinical Diagnostics – VITROS (EUN to FDA accepted)
  • Qiagen – QIAreach™ SARS-CoV-2 Antigen Test (announced launch)
  • Quidel – Sofia 2 SARS-COV-2 Antigen Test
  • Roche – SARS-CoV-2 Rapid Antigen Test (CE)
  • Sona Nanotech – Sona COVID-19 Rapid Antigen Test
  • Tigsun Diagnostics – COVID-19 Antigen Saliva Rapid Test

In addition to these tests, Roche has announced its intention to launch a lab-based antigen test, Ortho Clinical Diagnostics has submitted notice for emergency use of a lab-based antigen test on its VITROS system, and Quidel has submitted a rapid, visually read SARS-CoV-2 antigen test on its QuickVue product line to the EUA.

Kalorama’s report said that antigen tests will not replace PCR but both testing types will fuel growth until the disease recedes or a pharmaceutical intervention is found, widely distributed and changes disease patterns. Kalorama’s report can be found here: https://kaloramainformation.com/product/covid-19-update-clinical-testing-telehealth-vaccines-and-other-markets/

About Kalorama Information:

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Share article on social media or email:

G-CON Manufacturing Collaborates with Avantor® to Fast-Track Diagnostic Testing


VWR, Avantor, G-CON, POD

Mobile LabPOD: Fully equipped, mobile lab units to fast-track delivery of diagnostic testing

Combining our expertise in scientific workflow processes with G-CON’s extensive capabilities in fabricating mobile cleanroom and lab solutions is a natural fit to help reinvent diagnostic testing.

G-CON Manufacturing, Inc., the global leader in prefabricated flexible cleanroom solutions, announced today a collaboration with Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, to offer fully equipped, mobile lab units to fast-track delivery of diagnostic testing.

The mobile LabPOD can support immediate diagnostic testing, such as that required for COVID-19. The collaboration will help ensure critical at-site testing capability and streamline the diagnostic testing process. Lab operators will have the ability to mobilize their analytical capabilities near collection locations, eliminating lengthy waiting times for results.

“The COVID-19 pandemic has made it clear that patient access to testing is only one part of the COVID test equation,” Maik Jornitz, CEO of G-CON explained. “The other crucial part is testing the sample, and that test has been performed off-site in most cases. With the mobile test lab, we can place the test capabilities at the sampling location and gain speed, which in turn could slow the infection rate, since we will know whether a person tests positive or negative much faster. For the G-CON team, we saw that our mobile platform could support this need and we are grateful for the support of Avantor’s team and product portfolio to deliver a fully functional solution.”

“Addressing the need to help prevent the spread of COVID-19 is paramount,” said Frederic Vanderhaegen, Executive Vice President, Americas and Europe, at Avantor. “Combining our expertise in scientific workflow processes with G-CON’s extensive capabilities in fabricating mobile cleanroom and lab solutions is a natural fit to help reinvent diagnostic testing. We are proud to play a critical role in supporting diagnostic testing, as well as in the drug development phases of research, clinical trials and the production of approved therapies and vaccines. This collaboration is another example of how Avantor sets science in motion to create a better world.”

Avantor has provided the overall guidance for the scientific station design within the mobile lab, including technical expertise for processes and configuration, and will outfit the entire lab with equipment and supplies to accurately test samples. Avantor will also provide the products used during diagnostic testing.

In addition to being used for at-site COVID-19 diagnostic testing locations, Mobile Test LabPODs can be used and reconfigured for multipurpose testing capabilities, including microbial and analytical evaluations, as well as training purposes.

About G-CON Manufacturing

G-CON Manufacturing designs, builds and installs prefabricated G-CON POD® cleanrooms. G-CON’s POD® portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD® cleanroom units surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing the PODs® once the production process reaches its lifecycle end. For more information, please visit G-CON’s website at http://www.gconbio.com.

About Avantor

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.

G-CON Manufacturing Contact

Brittany Berryman

Director of Marketing

M: 979-204-7975

bberryman@gconbio.com

Avantor Media Contact

Robert Donohoe

Senior Director, Corporate Communications

Avantor

M: 484-688-4730

Robert.Donohoe@avantorsciences.com

Share article on social media or email:



CEO and President Jason Provenzano Named 2020 Winner in the Business Intelligence Group Awards for Business


CEO and President Jason Provenzano Named 2020 Winner in the Business Intelligence Group Awards for Business

I am honored to be recognized by the Business Intelligence Group, but none of our success would be possible without my extraordinarily hardworking team and the clients who rely so heavily on our services.

Today, CEO and President of Long Island-based Makers Nutrition received the Business Intelligence Group’s BIG Award for Business and was named the 2020 Entrepreneur of the Year. The Business Intelligence Group’s annual program honors companies, products and people that are leading their respective industries.

From strategic management to innovative solutions, Jason Provenzano has led Makers Nutrition into its top position in the nutraceutical industry. A recipient of the 2020 BIG Excellence in Customer Service award and a grand International Business Awards honoree, Makers Nutrition has served an unprecedented client volume during the COVID-19 crisis. Having not closed one day during the pandemic, Mr. Provenzano made it his priority to show clients exactly the type of company he has fostered, and that he did.

“I am honored to be recognized by the Business Intelligence Group, but none of our success would be possible without my extraordinarily hardworking team and the clients who rely so heavily on our services,” said Mr. Provenzano. “I look forward to growing with those clients and making an even greater impact on so many of their customers’ health.”

“We are so proud to recognize Mr. Provenzano for his outstanding 2020 achievements,” said Maria Jimenez, chief nomination officer of the Business Intelligence Group. “This year’s winners are clearly leading by example in the global business community.”

About Makers Nutrition

Makers Nutrition, an Inc. 5000 Fastest-Growing Company in America, is a groundbreaking provider for dietary supplement companies worldwide. Specializing in capsules, tablets, powders, softgels and gummies, Makers Nutrition provides a full-service option for all contract manufacturing, graphic design, packaging, and fulfillment service needs.

About the Business Intelligence Group

The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, business executives—those with experience and knowledge—judge the programs. The organization’s proprietary and unique scoring system selectively measures performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers.

Share article on social media or email:

Ban-Koe Companies Announces New COVID-19 Self-Screening Solution for Employees, Customers & Visitors


vIDix iReport On Phone

vIDix iReport Self-Screening Solution

The U.S. Chamber of Commerce states “… the threat of lawsuits from employees or customers…is the business community’s greatest area of concern.”

OSHA Occupational Safety & Health Association encourages self-screening to start at home before exposing anyone in the workplace or surrounding area. “In many workplaces, temperature screening efforts are likely to be most beneficial when conducted at home by individual workers, with employers’ temperature screening plans relying on workers’ self-monitoring and staying home if they have a fever or other signs or symptoms of illness, rather than employers directly measuring temperatures after workers arrive at the work site.”

vIDix iReport, one of the very first and most effective screening tools provides a safe self-reporting health screening solution. Ban-Koe has taken an ongoing proactive approach regarding the symptoms and risk factors each of us must face every day before entering the workplace when creating vIDix iReport.

“The workday starts long before an employee is at their desk,” states Richard Metcalf, VP of Channel Sales. “The workday starts on the way to work, via bus, rail, car, bicycle. The coronavirus remains in the breathable air for up to three hours. Walking from your car or the bus stop can still be a critical situation for any of us. Simply wearing masks is not always enough.”

The U.S. Chamber of Commerce states “… the threat of lawsuits from employees or customers…is the business community’s greatest area of concern.”

vIDix iReport provides that extra proactive screening that is needed for a truly safe workplace not only for employees, but for customers and visitors as well.

“Our vision is to enact safety measures long before the employee or persons reach the place of business,” continues Metcalf. “Our vIDix products start before the workday begins by properly scheduling the right person at the right place at the right time. Then self-screening at home instead of waiting until they get to work to punch-in thereby exposing co-workers and customers to potential threats not only COVID-related, but also flu and other viral potentials.”

“Once at the workplace,” states Metcalf, “our vIDix security products provide authorized and contactless facility access and time-tracking. Plus, if desired, our vIDix products can share detailed access and screening information for day-to-day management and aid with contact tracing in the event of possible exposure in the workplace. At the business owner’s prerogative, automated notices can be sent to those who have become potentially exposed to COVID-19 or other tracked illnesses. Ban-Koe is the undoubtable leader in taking simple time and attendance to a whole new level for a complete integrated solution capturing Workforce Management and Workplace Security. With a 40-year history of providing solutions, Ban-Koe has been providing state-of-the-art innovation longer than many companies have been in business.”

Ban-Koe’s priority remains the health and safety of our employees, partners, and customers while also providing efficiency and accuracy in the workplace.

About vIDix iReport

Easily capture CDC recommended health screening information for all individuals entering your building, business, project site or campus. Quickly allow your visitors to respond to the screening questions using their personal device or kiosk. Use collected information to quickly and easily communicate positive cases when managing contact tracing. Learn more here: https://youtu.be/uZSUJempkxU

About Ban-Koe Companies

Ban-Koe Companies provides Workforce Management and Workplace Security solutions to thousands of organizations worldwide. Solutions including Self-Screening, Time Accounting, Advanced Scheduling, Access Control, Visitor Management and more provides our customers with solutions to meet today’s challenges. Ban-Koe Companies is the industry leader in providing standalone-integrated solutions to clients, dealers, distributors and OEMs. For distribution information contact: Richard Metcalf at 612-900-4717 or richard.metcalf@vIDixSolutions.com. To learn more visit http://www.vidixsolutions.com/covid-19 or http://www.linkedin.com/company/ban-koe

Share article on social media or email:

Dalton Pharma Services Announces New Analytical Service: Extractables and Leachables


Dalton Pharma Services, a leading North-American contract drug manufacturing organization is pleased to announce the addition of instrumentation to perform extractables and leachables determining on container closure systems.

Extractables are organic and inorganic contaminants such as plasticizers, elastomers, oligomers, dyes, elemental impurities etc. that can be extracted from the surfaces of packaging components under extreme conditions such as elevated temperature and pressure or with exposure to organic solvents. Leachables are defined as organic and inorganic contaminants that can be released from the surface of container closure systems under standard storage conditions.

Extractables and leachables (E&Ls) may be inherently toxic and can contaminate the drug product. The enhanced regulatory standards necessitates pharma industry to develop sensitive and accurate analytical methods to detect, identify, and quantitate extractables and leacheables in drug product, as per U.S. FDA 21 CFR 211.94(a) and European Commission Directive (2001/83/EC).

“We are excited to add extractables and leachables contract analytical testing services to our Drug Development capabilities. Dalton can now ensure that container closure systems in aseptic fill/finish are suitable in the development of our innovative clients’ new medicines. Adding this service to Dalton’s drug development and manufacturing capabilities ensures that our client’s products are free from impurities and sources of contamination in our clients products from containers and packaging materials,” said Peter Pekos, CEO Dalton, Pharma Services.

About Dalton:

Dalton Pharma Services is a leading North American cGMP pharmaceutical organization providing integrated drug discovery, development and manufacturing services. We are FDA inspected and Health Canada approved and bring over 30 years of experience to every project. We deliver fully integrated solutions with an emphasis on speed, flexibility and quality. Our integrated services (drug discovery, formulation and process development, custom synthesis, cGMP sterile fill/finish of liquids and powders, cGMP API manufacturing and/or dosage form manufacturing and Accelerated Stability Testing) all at one location helps us to be adaptable, flexible and cost-effective.

To learn more about Dalton visit https://www.dalton.com.

Media contacts:

Peter Pekos

CEO

Dalton Pharma Services

349 Wildcat Road

Toronto, Ontario

Tel: 416-661-2102

Share article on social media or email:

Mental Health Startup, Taliaz, Awarded $2.7 Million EU Horizon 2020 Grant


Taliaz is revolutionizing the treatment and management of mental health disorders with PREDICTIX

Taliaz is revolutionizing the treatment and management of mental health disorders with PREDICTIX

The funds will support our mission to improve patient wellbeing and reduce associated costs by ensuring every patient gets the right mental health treatment, the first time.” Dekel Taliaz, CEO & Co-founder of Taliaz

Taliaz, a mental health startup harnessing artificial intelligence (AI) to revolutionise mental health treatment and management, today announced that it was awarded $2.7 million in funding from the European Union (EU) Horizon 2020 program. The grant will support clinical research expansion and the ongoing development of PREDICTIX, Taliaz’s pioneering decision-support and management platform for mental health. The research will focus on further validating the efficacy of the PREDICTIX platform in depression in multiple EU countries.

Today, more than 84 million people suffer from mental health disorders in Europe, with mental health conditions accounting for about 13% of the global burden of disease. Yet, in the field of depression, the right antidepressant is only prescribed in 49% of cases. This can lead patients to suffer up to 6-18 months of pain and suffering trialing different treatments.

Taliaz’s CE-registered product, PREDICTIX, harnesses AI to empower psychiatrists and general practitioners’ treatment decisions and can improve today’s prescribing accuracy by 47%*.

The PREDICTIX technology uses AI to help doctors overcome current challenges in treating complex and multifaceted mental health conditions. Their successful treatment depends on understanding the relationships between patients’ genetic, metabolic, demographic and clinical information. By combining data science and machine learning with deep clinical and biological scientific research, the PREDICTIX mental health platform translates these thousands of data combinations into an easy-to-use assessment and management software to empower prescribing decisions for a faster patient recovery.

Dekel Taliaz, CEO and Co-founder of Taliaz said, “We are excited to receive the prestigious Horizon 2020 grant. The funding from the European Commission endorses the strong science behind our approach. This is especially important as mental health rises across the globe during the COVID-19 pandemic. The funds will support our mission to improve patient wellbeing and reduce associated costs by ensuring every patient gets the right mental health treatment, the first time.”

Taliaz is currently in the process of raising a further round of investment to accelerate and expand commercial efforts with health care systems, payors, providers, DNA laboratories and telemedicine providers globally.

*Based on a retrospective analysis of STAR*D study medications versus current clinician treatment selection prescribing accuracy (Chekroud et al., 2016). STAR*D is one of the world’s largest prospective studies for optimal antidepressant administration.

About Taliaz

Taliaz is revolutionizing the treatment and management of mental health disorders with PREDICTIX. PREDICTIX is a CE-registered product that provides an advanced decision support software for psychiatrists and general practitioners. Harnessing artificial intelligence, PREDICTIX can enable easy, effective and rapid patient assessment, improved prescribing precision and management for a wide range of mental health conditions. Starting in the field of depression, the PREDICTIX Genetics and PREDICTIX Digital products can improve today’s prescribing accuracy by up to 47%*. Learn more at predictix.ai.

Share article on social media or email:

Charleston, West Virginia, Ranks #1 in CAPC’s Top 10 Cities ROUNDWORM Report for Highest Percent Increase in Positive Tests of Dogs & Cats in Past Month


Roundworms (toxocara canis) are the most common intestinal parasite in pets.

It’s our hope that the new CAPC Top 10 Cities Monthly ROUNDWORM Report will prompt important conversations between pet owners and their veterinarians about roundworm protection.

The Companion Animal Parasite Council (CAPC) — the nation’s leading source on parasitic diseases that threaten the health of pets and people — today issued the CAPC Top 10 Cities Monthly ROUNDWORM Report for the past month — with Charleston, West Virginia, topping the list at #1 across the country.

The new monthly report alerts pet parents, veterinarians and pet-related services about the threat of roundworm infection — a zoonotic, parasitic disease threatening the health of both pets and people. The report identifies U.S. metro areas experiencing the highest percentage increase in positive roundworm tests in the last 30 days.

“The recent outbreak of COVID-19, with its animal origin, has made people acutely aware of the close relationship between animal and human health — and the need to regularly monitor disease at the local level,” said Dr. Chris Carpenter, DVM and CAPC’s Chief Executive Officer. “With the ever-present threat of roundworm infections – particularly during fall and winter months – CAPC expands its decade-long mission to regularly monitor parasitic diseases in communities across the U.S. with its new CAPC Top 10 Cities Monthly ROUNDWORM Report.”

Roundworm can be lethal, particularly for puppies and kittens. In national data collected October 1 – 31, 2020, these 10 U.S. cities had the highest percentage increase in positive roundworm tests:

1) Charleston, West Virginia

2) Mobile, Alabama

3) Wichita, Kansas

4) Killeen, Texas

5) Little Rock, Arkansas

6) Miami, Florida

7) Memphis, Tennessee

8) Alexandria, Virginia

9) Winston-Salem, North Carolina

10) Visalia, California

“An increase in roundworm prevalence not only alerts communities to a persistent threat to the health of dogs and cats, but it also warns of a significant threat to the health of children and families who can potentially contract roundworm infection,” said Dr. Craig Prior, BVSC, CVJ, CAPC board member.

Surveys of fecal samples from across the U.S. show that more than 30 percent of dogs younger than 6 months of age are shedding Toxocara canis (roundworm) eggs — with CAPC parasite prevalence maps reporting positive cases of roundworm infection in both dogs and cats in all 50 states. Due to the high prevalence of roundworm, it can be assumed that virtually every puppy or kitten is infected at or soon after birth.

“This demonstrates how vital it is for dogs and cats to be protected against roundworm parasites with broad-spectrum, year-round preventatives, and at a minimum, bi-annual testing,” Prior added. “By protecting your pet, you are protecting other pets, your family, other families — and your entire community.”

WHAT ARE ROUNDWORMS?

Roundworms (toxocara canis) are the most common intestinal parasite in pets. Dogs and cats can become infected through ingestion of roundworm eggs in the environment or from eating infected hosts such as rodents or birds. Infected dogs and cats then shed the microscopic roundworm eggs back into the environment in their feces, compounding the cycle of infection.

  • Symptoms of roundworm infection include weight loss, diarrhea, vomiting, dull coat, and/or a pot-bellied appearance. Severe infections can result in death.
  • Prevalence of roundworm infection is higher in fall and winter months. Because roundworm eggs have a strong protective layer, they are not sensitive to extreme temperatures and can survive in the environment for months — and even years.
  • Roundworm infection is most severe in puppies and kittens. The disease can be transmitted directly from the mother to puppies and kittens from nursing worm larvae from the mother’s milk. Puppies may be infected with roundworm from the time they are born because the mother can pass roundworm to the puppy through the placenta (this is not the case with kittens.)

Can humans be harmed by roundworm?

Roundworms pose a significant risk to humans — and are most common in children. People can be infected from handling and accidentally ingesting dirt containing roundworm larva that can migrate to the liver, lungs, muscle and brain. Children are more likely to be infected after playing in contaminated soil. Clinical symptoms vary but are often characterized by fever, malaise, cough and abdominal pain. Severe infections may cause respiratory failure or blindness.

RISK FACTORS FOR ROUNDWORM EXPOSURE

Pets living in cities on this month’s CAPC Top 10 Cities Monthly ROUNDWORM Report may have been exposed due to several risk factors:

  • Any outdoor area where dogs and cats have access can become reservoirs for roundworm. Typical areas of contamination include neighborhood streets and common areas, gardens, parks, playgrounds, sandboxes, beaches, rest areas — and your own backyard. It’s also critical to regularly clean pet’s indoor living areas —including bedding, bowls, balls and other toys — and clean cat litter boxes daily.
  • Prompt removal of pet feces is critical to preventing the spread of roundworm. In communities across the country, dog owners not picking up their dog’s stool is a contentious issue — and for good reason. According to the U.S. Environmental Protection Agency, 40% of dog owners don’t pick up dog stool. “Dog owners need to be diligent in immediately removing fecal waste in public areas — and at least once a week in their own backyards,” Prior said. “It’s more than a cosmetic issue. Pet owners who are irresponsible in picking up after their dogs are putting the health of their own dog, other dogs — and the health of everyone in their community at risk
  • Dog parks are quickly becoming a standard feature in many communities. A recent study by The Trust for Public Land reported 744 off-leash dog parks in the top 100 cities in the U.S. in 2018 — a 40% increase since 2009. And studies reveal that 27% of fecal samples collected in dog parks contained GI parasites (roundworm, hookworm or whipworm). “The popularity of dog parks is a major factor in the persistent number of roundworm infections. Unlike boarding or day care facilities, dog parks don’t require proof of immunization and parasite protection,” Prior said. “And while dog parks provide a unique opportunity for dogs to exercise, it’s not uncommon for dog owners to socialize, and while not paying close attention — even for a few minutes — their dog defecates, leaving stool behind as a potential source of infection.”
  • Compliance in testing and protecting pets. CAPC recommends puppies and kittens be tested at least four times in the first year of life for roundworm and other intestinal parasites; and at least two times every year in adults. CAPC also recommends that all dogs and cats be protected with monthly broad-spectrum parasite control with efficacy against roundworm year-round. To pinpoint risk for roundworm, CAPC parasite prevalence maps provide roundworm prevalence in every U.S. county.


“For nearly a decade, CAPC has been a national leader in monitoring parasitic diseases that threaten pets and people with timely, local disease prevalence maps,” Carpenter said. “It’s our hope that the new CAPC Top 10 Cities Monthly ROUNDWORM Report will prompt important conversations between pet owners and their veterinarians about roundworm protection.”

ABOUT CAPC

The Companion Animal Parasite Council (http://www.capcvet.org) is an independent not-for-profit foundation comprised of parasitologists, veterinarians, medical, public health and other professionals that provides information for the optimal control of internal and external parasites that threaten the health of pets and people. Formed in 2002, CAPC works to help veterinary professionals and pet owners develop the best practices in parasite management that protect pets from parasitic infections and reduce the risk of zoonotic parasite transmission.

Share article on social media or email: